Nautilus Biotechnology, Inc. (NAUT)

Market Cap	398.53M
Revenue (ttm)	n/a
Net Income (ttm)	-58.25M
Shares Out	124.93M
EPS (ttm)	-0.46
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	52,448
Open	3.46
Previous Close	3.46
Day's Range	3.15 - 3.49
52-Week Range	1.50 - 4.65
Beta	0.97
Analysts	Hold
Price Target	6.00 (+88.09%)
Earnings Date	Oct 31, 2023

About NAUT

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was incorporated in 2016 and is headquartered in Seattle, Washington.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2016
• Employees: 153
• Stock Exchange: NASDAQ
• Ticker Symbol: NAUT

Analyst Forecast

According to one analyst, the rating for NAUT stock is "Hold" and the 12-month stock price forecast is $6.0.

Price Target

$6.0

(88.09% upside)

Analyst Consensus: Hold